Bladder cancer.
- 28 March 1981
- Vol. 282 (6269) , 1012-1013
- https://doi.org/10.1136/bmj.282.6269.1012
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Serum Beta2-Microglobulin in Acute and Chronic LeukaemiaScandinavian Journal of Haematology, 2009
- TNM (1978) in Bladder Cancer: Use and AbuseBritish Journal of Urology, 1980
- Serum β 2-microglobulin in myelomatosis: potential value in stratification and monitoringBritish Journal of Cancer, 1980
- Diagnosis of Leukemia or Lymphoma in the Central Nervous System by Beta2-Microglobulin DeterminationNew England Journal of Medicine, 1980
- Chemotherapy of Metastatic Bladder CancerCancer, 1980
- Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patientsCancer, 1980
- The Survival of Patients with Bladder Tumors Treated by Surgery: Comparative Results of an Old and a Recent SeriesJournal of Urology, 1979
- Serial Multiple-Site Biopsies in Patients with Bladder CancerJournal of Urology, 1978
- The Natural History of Papillary Transitional Cell Carcinoma of the Bladder and its Treatment in an Unselected Population on the Basis of Histologic GradingJournal of Urology, 1978
- Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 1976